Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Venus Remedies Ltd (VENUSREM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3326
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Venus Remedies Ltd (Venus) is a pharmaceutical company that develops, manufactures and commercializes research, herbal and generic products. The company’s manufactures products for analgesic and antipyretic, antibiotic, anticoagulant, disinfectant and antiseptic, iron supplement, neurology, respiratory, oncology, and vitamins supplements. Venus is also engaged in research of Antimicrobial Resistance (AMR), a resistance which works against the microorganisms such as viruses (HIV), bacteria (causes pneumonia), and some parasites (Malaria). The company operates through its injectable manufacturing units located in Panchkula and Baddi, India; and Werne, Germany. Venus is headquartered in Panchkula, Haryana, India.

Venus Remedies Ltd (VENUSREM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug 11
Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem 12
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 13
Licensing Agreements 14
Venus Remedies May Enter into Licensing Agreement with Europe and US Company 14
Venus Remedies to Enter into License Agreement with Austell Lab for Elores 15
Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem 16
Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores 17
Equity Offering 18
Venus Remedies Withdraws Private Placement of Shares 18
Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million 19
Asset Transactions 20
China Medical System Acquires Six Products from Venus Pharma 20
Venus Remedies Ltd – Key Competitors 21
Venus Remedies Ltd – Key Employees 22
Venus Remedies Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
May 30, 2017: Venus Remedies Reports Total Income Of INR4 Billion In Fiscal 2017 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venus Remedies Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Venus Remedies Enters into Agreement with Teva Pharma for Anti Cancer Drug 11
Venus Pharma Enters Into Co-Marketing Agreement With Mylan For Meropenem 12
Venus Remedies Enters Into Co-Marketing Agreement With Adcock For Potentox 13
Venus Remedies May Enter into Licensing Agreement with Europe and US Company 14
Venus Remedies to Enter into License Agreement with Austell Lab for Elores 15
Venus Pharma Enters into Licensing Agreement with Mylan for Meropenem 16
Venus Remedies Enters Into Licensing Agreement With Goodwills For Elores 17
Venus Remedies Withdraws Private Placement of Shares 18
Venus Remedies Plans Private Placement Of Shares For Up To US$30 Million 19
China Medical System Acquires Six Products from Venus Pharma 20
Venus Remedies Ltd, Key Competitors 21
Venus Remedies Ltd, Key Employees 22
Venus Remedies Ltd, Other Locations 23
Venus Remedies Ltd, Subsidiaries 23

List of Figures
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Venus Remedies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Venus Remedies Ltd (VENUSREM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nurix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Nurix Inc (Nurix) formerly Kura Therapeutics Inc, is a drug development company that discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system ( …
  • Suelopetrol CA SACA:企業の戦略的SWOT分析
    Suelopetrol CA SACA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • VWR International LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary VWR International LLC (VWR), a subsidiary of Avantor Performance Materials Inc, is a provider of product and service solutions to laboratory and production companies. The company offers products such as adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshe …
  • Akbank TAS (AKBNK):企業の財務・戦略的SWOT分析
    Akbank TAS (AKBNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Enercon GmbH-エネルギー分野:企業M&A・提携分析
    Summary Enercon GmbH (Enercon) is a renewable energy equipment company that manufactures and supplies wind energy converters (WEC). It produces components of the WECs including annular generators, inverters, rotor blades, cast components, towers and machine houses. Enercon provides electrical and me …
  • LOT Polish Airlines SA:企業の戦略・SWOT・財務分析
    LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report Summary LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • NicOx SA (COX):企業の財務・戦略的SWOT分析
    Summary NicOx SA (NicOx) is an ophthalmology company that develops solutions to help maintain vision and improve ocular health. The company’s products include Vyzulta, a latanoprostene bunod ophthalmic solution; and Zerviate, a cetirizine ophthalmic solution. It offers products in the therapeutic ar …
  • Ashland Global Holdings Inc (ASH):企業の財務・戦略的SWOT分析
    Ashland Global Holdings Inc (ASH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Congenica Ltd-医療機器分野:企業M&A・提携分析
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers research and experimental development on biotechnology. The company’s technology SAPIENTIA, is used to personalize patient care through accurate diagnoses, support clinical trials, and drug development. It offers services such …
  • Sinopec Shanghai Petrochemical Company Limited:企業の戦略・SWOT・財務分析
    Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report Summary Sinopec Shanghai Petrochemical Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Odebrecht S.A.:企業の戦略・SWOT・財務分析
    Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report Summary Odebrecht S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Glow Energy Public Co Ltd:発電所・企業SWOT分析
    Glow Energy Public Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emp …
  • Aarti Industries Ltd (AARTIIND):企業の財務・戦略的SWOT分析
    Summary Aarti Industries Ltd (Aarti Industries) is a chemical company that manufactures and markets benzene based basic and intermediate chemicals. It offers chemicals, pharma products and surfactants including rubber chemicals, dyes and pigment intermediates; surfactant intermediates, pharmaceutica …
  • Power Solution Technologies Public Company Ltd (PSTC):電力:M&Aディール及び事業提携情報
    Summary Power Solution Technologies Public Company Ltd (PST) is an energy company that offers solar products, technology systems, products and services. The company operates through its business divisions such as power and energy, and power producers. Its power and energy division generates datacent …
  • DormaKaba Holding AG:企業の戦略・SWOT・財務情報
    DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report Summary DormaKaba Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • PotlatchDeltic Corporation (PCH):企業の財務・戦略的SWOT分析
    PotlatchDeltic Corporation (PCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Expeditors International of Washington, Inc.:企業の戦略・SWOT・財務情報
    Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report Summary Expeditors International of Washington, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Bonheur ASA (BON):企業の財務・戦略的SWOT分析
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆